Biotech | August 12, 2021
Global cell expansion market poised for huge growth
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
This work has been published in the journal ‘ACS applied materials and interface’
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
Earlier, the USFDA has granted ‘Orphan Drug Designation’ and ‘Fast Track Designation’ to Saroglitazar Mg for PBC
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
The new platform is the latest initiative under Lupin’s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailment
Subscribe To Our Newsletter & Stay Updated
